Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Mylan recalls batches of Valsartan in US.

      Mylan recalls batches of Valsartan in US.

      Medical Dialogues Bureau21 Nov 2018 11:05 AM IST
      Mylan NV said on Tuesday it would recall certain batches of blood pressure medicine valsartan in the United States after they were found to contain a...
      MTaI demands upto 18 percent price hike of medical devices

      MTaI demands upto 18 percent price hike of medical devices

      Medical Dialogues Bureau21 Nov 2018 10:54 AM IST
      Hike required to neutralize the impact of rupee depreciation & inflationNew Delhi: Medical Technology Association of India (MTaI), which...
      Pharma Industry needs to Self Regulate: Dr RK Vats, Chairman, NPPA

      Pharma Industry needs to Self Regulate: Dr RK Vats, Chairman, NPPA

      Medical Dialogues Bureau21 Nov 2018 10:46 AM IST
      New Delhi:The 15th National Pharmaceutical Conclave, organized by the Confederation of Indian Industry (CII) in partnership with the Department of...
      Zydus Cadila gets USFDA nod to market generic Deferasirox tablets

      Zydus Cadila gets USFDA nod to market generic Deferasirox tablets

      Medical Dialogues Bureau21 Nov 2018 10:44 AM IST
      New Delhi: Drug firm Zydus Cadiz Tuesday said it has received the tentative nod from the US health regulator to market generic Deferasirox tablets...
      Glenmark gets USFDA nod for generic acne treatment gel

      Glenmark gets USFDA nod for generic acne treatment gel

      Medical Dialogues Bureau21 Nov 2018 9:00 AM IST
      New Delhi: Glenmark Pharmaceuticals Tuesday said it has received approval from the US health regulator for Azelaic Acid gel used in the treatment of...
      EU cracks down on Valsartan- blood pressure medicine made by Mylan

      EU cracks down on Valsartan- blood pressure medicine made by Mylan

      Medical Dialogues Bureau20 Nov 2018 12:05 PM IST
      The batches of Valsartan were found to contain N-nitrosodiethylamine (NDEA), a probable carcinogen, and were made in Mylan's Hyderabad facility in...
      We have NO power to block online Pharmacies: Tamil Nadu govt tells Court

      We have NO power to block online Pharmacies: Tamil Nadu govt tells Court

      Medical Dialogues Bureau20 Nov 2018 11:47 AM IST
      Chennai: The Tamil Nadu government Monday informed the Madras High Court that it did not have the power to block websites selling medicines in the...
      Greece eyes pot of gold as medicinal cannabis licensed

      Greece eyes pot of gold as medicinal cannabis licensed

      Medical Dialogues Bureau20 Nov 2018 9:00 AM IST
      ATHENS - Greece on Monday issued the first licences to private companies for growing medicinal cannabis in the country, part of an attempt to tap a...
      GE Capital sells 1.5 billion dollar healthcare equipment portfolio to TIAA

      GE Capital sells 1.5 billion dollar healthcare equipment portfolio to TIAA

      Medical Dialogues Bureau19 Nov 2018 1:47 PM IST
      New Delhi: General Electric Co has recently announced its lending arm has sold a $1.5 billion healthcare equipment finance portfolio to U.S. lender...
      Pfizer to raise US drug prices in January after previously backing down under Trump pressure

      Pfizer to raise US drug prices in January after previously backing down under Trump pressure

      Medical Dialogues Bureau19 Nov 2018 1:14 PM IST
      NEW YORK: Pfizer Inc has recently announced that it plans to hike U.S. prices on 41 of its medicines in January, after walking back its previous...
      Aurobindo Pharma to launch oncology, respiratory products in US by 2021

      Aurobindo Pharma to launch oncology, respiratory products in US by 2021

      Medical Dialogues Bureau19 Nov 2018 10:23 AM IST
      For the long-term, from 2022 onwards, Aurobindo Pharma plans "launch of inhalers, transdermals, biosimilars, and branded (both Rx and OTC) products in...
      Novartis completely committed to Sandoz, has no split-off plan

      Novartis 'completely committed' to Sandoz, has no split-off plan

      Medical Dialogues Bureau19 Nov 2018 9:40 AM IST
      ZURICH: Swiss drugmaker Novartis is "completely committed" to its $10 billion-per-year Sandoz generics business, a spokesman said on Thursday after a...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok